XML 32 R23.htm IDEA: XBRL DOCUMENT
v3.19.1

Revenues (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2019
Revenue from Contract with Customer [Abstract] |
Disaggregation of revenue by product and by geographic area | Revenues were as follows (in millions):
|  | Three months ended March 31,
|  | 2019 |  | 2018
|  | US |  | ROW |  | Total |  | US |  | ROW |  | Total
Enbrel® (etanercept) |  | $ | 1,106 |  |  | $ | 45 |  |  | $ | 1,151 |  |  | $ | 1,050 |  |  | $ | 55 |  |  | $ | 1,105 |
Neulasta® (pegfilgrastim) |  | 893 |  |  | 128 |  |  | 1,021 |  |  | 1,009 |  |  | 146 |  |  | 1,155 |
Prolia® (denosumab) |  | 390 |  |  | 202 |  |  | 592 |  |  | 320 |  |  | 174 |  |  | 494 |
XGEVA® (denosumab) |  | 356 |  |  | 115 |  |  | 471 |  |  | 332 |  |  | 113 |  |  | 445 |
Aranesp® (darbepoetin alfa) |  | 182 |  |  | 232 |  |  | 414 |  |  | 225 |  |  | 229 |  |  | 454 |
KYPROLIS® (carfilzomib) |  | 154 |  |  | 91 |  |  | 245 |  |  | 137 |  |  | 85 |  |  | 222 |
EPOGEN® (epoetin alfa) |  | 219 |  |  | — |  |  | 219 |  |  | 244 |  |  | — |  |  | 244 |
Sensipar®/Mimpara® (cinacalcet) |  | 135 |  |  | 78 |  |  | 213 |  |  | 409 |  |  | 88 |  |  | 497 |
Other products |  | 556 |  |  | 404 |  |  | 960 |  |  | 421 |  |  | 306 |  |  | 727 |
Total product sales(1) |  | $ | 3,991 |  |  | $ | 1,295 |  |  | 5,286 |  |  | $ | 4,147 |  |  | $ | 1,196 |  |  | 5,343 |
Other revenues |  |  |  |  |  | 271 |  |  |  |  |  |  | 211 |
Total revenues |  |  |  |  |  | $ | 5,557 |  |  |  |  |  |  | $ | 5,554 |
____________
(1) | Hedging gains and losses, which are included in product sales, were not material for the three months ended March 31, 2019 and 2018.

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration